Search results

Articles (7)

Journals (0)

1-7 of 7 results for multiday chemotherapy

Sort by:

Relevance

Select all

Sort by:

Relevance

Retricted access

Research article

First published 2012-12

Effectiveness of Palonosetron Versus Other Serotonin 5-HT3 Receptor Antagonists in Triple Antiemetic Regimens During Multiday Highly Emetogenic Chemotherapy

Kyung Im Kim, Dong Eun Lee, Inhye Cho [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2025

Addition of an NK1 receptor antagonist to standard antiemetic prophylaxis in patients with B-cell lymphoma receiving EPOCH

Sloane English, Matthew Lei, Mark Sorial [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2023-08

Huo Xiang Zheng Qi Oral Liquid Combined with 5-HT3 Receptor Antagonists and Dexamethasone Can Prevent Chemotherapy-Induced Nausea and Vomiting for Patients Receiving Multiday Cisplatin-Based Regimen: A Multicenter Trial

Hao Wei, Yu Sun, Lingling Xie [...]

Journal of Integrative and Complementary Medicine

Retricted access

Research article

First published 2014-8

Combined use of multiday palonosetron with aprepitant and low-dose dexamethasone in prevention of nausea and emesis among patients with multiple myeloma and lymphoma undergoing autologous hematopoietic stem cell transplant: A pilot study

Delva Deauna-Limayo, Omar S Aljitawi, Siddhartha Ganguly [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2024-10

Olanzapine within steroid-sparing antiemetic regimen to prevent chemotherapy-induced nausea and vomiting in patients with acute leukemia receiving multi-day intensive chemotherapy

Grace Hsu, Ciera Bernhardi, Justin Lawson [...]

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2016

Granisetron Transdermal System in the Management of Chemotherapy-Induced Nausea and Vomiting

Hiromitsu Kitayama

Clinical Medicine Insights: Therapeutics

Retricted access

Research article

First published 2022-1

Evaluating the incidence of chemotherapy-induced nausea and vomiting in patients with B-cell lymphoma receiving dose-adjusted EPOCH and rituximab

Emma Uchida, Matthew M Lei, Eric Roeland [...]

Journal of Oncology Pharmacy Practice